THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net
S U M M A R Y
DIARY: March 29, 2010 11:22 PM Monday;
Rod Welch
Millie notifies medical team agenda meeting at Kaiser on March 30th.
1...Summary/Objective
..............
Click here to comment!
CONTACTS
SUBJECTS
Default Null Subject Account for Blank Record
0403 -
0403 - ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS 21 0000. ref SDS 18 0000.
040502 -
040503 -
040504 -
040505 -
040507 - ..
0406 -
0407 -
0408 - Background
0409 -
040901 - On 100203, Millie resumed treatment after a 3-week pause ordered by
040902 - Doctor Johnson, on 100112 0830, ref SDS 5 G68H, while Millie was
040903 - treated to recover from a very severe case of shingles infection,
040904 - reported earlier on 100104 1115. ref SDS 4 0P9S
040906 - ..
040907 - On 100217 0730 Millie got the 3rd treatment of the 3rd cycle with
040908 - Navelbine for Millie to recover from the 9th relaspe of cancer.
040910 - ..
040911 - On 100218 1000 Millie got Neupogen treatment at Kaiser to maintain
040912 - blood counts essential for getting Navelbine chemotherapy treatment
040913 - for cancer. ref SDS 8 ER95
040915 - ..
040916 - On 100218 1000 Millie had emergency meeting with Doctor Johnson,
040917 - primary care physician at Kaiser, after getting Neupogen treatment;
040918 - the doctor diagnosed relapse of shingles, and prescribed a 4th cycle
040919 - of treatment, but only with Acyclovir (Zovirax) 800 MG tablets,
040920 - ref SDS 8 0Y6O; the doctor also diagnosed Millie's 10 relapse of
040921 - cancer, and ordered switching treatment from Navelbine to Abraxane,
040922 - beginning on 100303. ref SDS 8 023N The doctor further ordered a CT
040923 - test to evaluate rising pain. ref SDS 8 ES40
040925 - ..
040926 - On 100218 1230 Millie had emergency CT test. ref SDS 8 PQ6R
040928 - ..
040929 - On 100301 0005 letter to medical team cites findings of "improvement"
040930 - reported in CT test on 100218, and increased energy may indicate
040931 - Navelbine can continue another cycle. ref SDS 9 ER95 Cancer marker CA
040932 - 15-3 328 suddenly increasing more than 100 points in a month, reflects
040933 - 3-week pause in treatment for cancer, orderd by the doctor as
040934 - necessary to treat shingles. ref SDS 9 OO3X The doctor prescribed
040935 - Abraxane to start the next cycle of chemotherapry to recover from the
040936 - 10th relapse of cancer; Millie is concerned about side effects.
040937 - ref SDS 9 OO4Q Chemotherapy is not appropriate care for treating
040938 - stage V cancer. ref SDS 9 OO7Q Millie needs another cetuximab
040939 - solution "targeted" to her patient profile to recover from cancer
040940 - without severe side effects. ref SDS 9 4Y6K Millie requests
040941 - explanation in writing of trade-offs comparing alternate oncology
040942 - treatments. ref SDS 9 OO7T Millie notifies Kaiser that
040943 - representations in the medical chart for the meeting on 091116 that
040944 - the doctor explained trade-offs is incorrect. ref SDS 9 OO9S Millie
040945 - notes that advantage of "targeted" treatments for cancer enables
040946 - concurrent treatment for recurrent shingles, rather than pausing,
040947 - which causes cancer to rapidly increase. ref SDS 9 OP6Q
040949 - ..
040950 - On 100302 0830 meeting at Kaiser, ref SDS 10 ER95; Doctor Johnson
040951 - prescribed Abraxane for Millie starting treatment tomorrow for
040952 - recovering from 10th relapse of cancer. ref SDS 10 FB67 Blood counts
040953 - dropped significantly, ref SDS 10 IC4N; since Abraxane side effects
040954 - reduce blood counts this increases chances of shingles recurrence; the
040955 - doctor advised that treatment for cancer will be paused again, if
040956 - shingles recurs. ref SDS 10 FC68 Only way for Millie to get treatment
040957 - for shinges concurrent with cancer is to switch from Abraxane to a
040958 - "targeted" treatment for cancer that does not injure bone marrow
040959 - producing blood. ref SDS 10 IC85
040961 - ..
040962 - On 100303 0730 Millie received 1st treatment 1st cycle Abraxane at
040963 - Kaiser Oncology Chemotherapy Clinic in Walnut Creek. ref SDS 11 625I
040965 - ..
040966 - On 100304 2251 Millie notifies medical team that 1st treatment of 1st
040967 - cycle started with Abraxane to recover from 10th relapse of cancer.
040968 - ref SDS 12 ER95 Reports possible recurrence of shingles. ref SDS 12
040969 - OP6W Millie asks Kaiser for written report on trade-offs for
040970 - prescribing agents "targeted" to treat her cancer that do no injure
040971 - the bone marrow producing new blood. ref SDS 12 OQ4Y
040973 - ..
040974 - On 100305 0822 Millie notifies medical team that shingles seems to
040975 - have subsided again, so that treatment with Abraxane can continue.
040976 - ref SDS 13 ER95 Millie requests prescription for medication to have
040977 - available in time to treat shingles recurrence so that treatment for
040978 - cancer can continue. ref SDS 13 0W3T Millie further requests that the
040979 - medical team submit analysis of trade-offs for alternative oncologic
040980 - treatments. ref SDS 13 0W3W
040982 - ..
040983 - On 100309 1238 Millie notifies medical team that shingles seems not to
040984 - have recurred despite side effects of Abraxane that lower immunity by
040985 - degrading bone marrow that replenishes blood counts. ref SDS 14 ER95
040987 - ..
040988 - On 100309 1238 Millie notifies medical team that Kaiser's Knowledge
040989 - Management system is off-line, and so requests results of blood test
040990 - to evaluate getting treatment with Abraxane chemotherapy tomorrow for
040991 - recovering from cancer. ref SDS 14 HL4V
040993 - ..
040994 - On 100309 1643 Millie notifies medical team that results of lab today
040995 - show "good-to-go" for getting 2nd Abraxane treatment tomorrow.
040996 - ref SDS 15 ER95
040998 - ..
040999 - On 100310 0730 Millie gets 2nd treatment 1st cycle of Abraxane to
041000 - recover from 10th relapse of cancer. ref SDS 16 KE4K; Doctor Johnson
041001 - visits Millie at 0810, during treatment, and approves getting
041002 - treatment. ref SDS 16 OR3H
041004 - ..
041005 - On 100310 1350 Millie thanks Doctor Johnson for visiting during
041006 - treatment today, ref SDS 17 ER95; notifies medical team that Kaiser
041007 - completed the 2nd treatment of the 1st cycle with Abraxane for
041008 - recovering from the 10th relapse of cancer. ref SDS 17 ER95 Doctor
041009 - Johnson advised that Kaiser's Knowledge Management internal email
041010 - system makes communication faster for emergency communications on
041011 - patient care. ref SDS 17 GY4U Millie reported that Kaiser's Knowledge
041012 - Management system has been off-line for more than a week. ref SDS 17
041013 - GY4X; Millie explains that public domain email addresses for doctors
041014 - at Kaiser enable comprehensive care that optimizes patient outcome,
041015 - even though it may be a little slower for emergencies. ref SDS 17 GY6P
041016 - Millie will continue to support the medical team through continuity of
041017 - communications for the doctor/patient partnership. ref SDS 17 GZ3U
041019 - ..
041020 - On 100311 0811 Doctor Johnson's letter dated 100310 said Millie may
041021 - need to get a new password. ref SDS 18 ER95
041023 - ..
041024 - On 100316 Millie went to Kaiser in Martinez for weekly blood draw to
041025 - test immune system to evaluate starting 2nd treatment for 3rd cycle of
041026 - Navelbine, and how much Nupigen treatment is needed to maintain blood
041027 - counts. ref SDS 19 AS5H Also testing INR 3.2 again, which was still
041028 - slightly high for interim blood test on 100205. ref SDS 7 IS7Q
041030 - ..
041031 - On 100317 0730 Millie received the 3rd treatment that completes the
041032 - 1st cycle with Abraxane to recover from the 10th relapse of cancer.
041033 - At this time, Millie is experiencing rising pain from progressing IBC,
041034 - and rising lymphedema, most noticably in the right arm, which has been
041035 - free of disease for 10 years. ref SDS 20 KE4K
041037 - ..
041038 - On 100319 0843 Millie notfies medical team that 1st cycle with
041039 - Abraxane chemotherapy was completed on 100317, and that she needs
041040 - dental work, which she will try to schedule for next week, which is
041041 - the bye-week for chemotherapy. ref SDS 21 ER95 Evident improvment in
041042 - cancer marker aligns with some initial reduction in IBC rash, which
041043 - together signal recovery from 10th relapse of cancer. ref SDS 21 1T3Y
041044 - Avoiding recurrence of shingles and avoiding drop in blood counts
041045 - supports the medical team treating Millie's cancer as a chronic
041046 - disease, planned by Doctor Rugo. ref SDS 21 1T4U
041048 - ..
041049 - On 100329 2322 Millie sent a letter notifying the medical team of
041050 - agenda for meeting at Kaiser tomorrow morning at 0830 with primary
041051 - care physician and for the purpose of evaluating continuing treatment
041052 - for a 2nd cycle with Abraxane chemotherapy, and comparing trade-offs
041053 - of alternate oncology treatments for recovering from the next relapse
041054 - of cancer. ref SDS 0 ER95
041055 -
041056 -
041058 - ..
0411 -
0412 -
0413 - Progress
0414 -
041401 - Millie's letter to medical team says...
041402 -
041403 - 1. Subject: Agenda Meeting at Kaiser Start Abraxane 2nd Cycle 10th Relapse Cancer
041404 - Date: Mon, 29 Mar 2010 23:58:20 -0700
041417 - ..
041418 - 2. We are meeting in the morning to evaluate starting 2nd cycle
041419 - with Abraxane to recover from the 10th relapse of cancer.
041420 -
041421 - [On 100330 0830 during the meeting at Kaiser Doctor Johnson
041422 - advised that he received and read Millie's letter today
041423 - submitting an agenda of issues for review to approve Millie
041424 - starting the 2nd cycle of chemotherapy. ref SDS 23 ER95
041426 - ..
041427 - 3. Initial results from the lab today show NEUTS (ANC) 3.2 within
041428 - the range 2.1 - 7.7 specified for safe chemotherapy, and well
041429 - above the minimum used in my case of 1.0 for approving
041430 - chemotherapy [...which was a major concern starting Abraxane,
041431 - because chemotherapy lowers blood counts, and Millie's blood
041432 - counts were below the level for safe chemotherapy on 100302
041433 - 0830. ref SDS 10 FC68; but, the next lab showed dramatic
041434 - recovery of blood counts a week after the first treatment with
041435 - Abraxane, reported on 100309 1643. ref SDS 15 2O8W...]
041437 - ..
041438 - 4. I don't have a strong sense of recovery as yet, in that
041439 - reduction of IBC rash seems significant some days, and at
041440 - different times of the day, but not sure on other days.
041442 - ..
041443 - 5. Similarly, lymphedema in the left arm and across my chest seems
041444 - less, but not sure.
041445 -
041446 - [On 100330 0830 Doctor Johnson finds during examination at
041447 - Kaiser that first cycle of treatment with Abraxane has
041448 - reduced Millie's cancer, ref SDS 23 FB9Y, including "drying
041449 - up" of IBC nodules. ref SDS 23 HR9K, and, so orders
041450 - starting 2nd cycle of Abraxane of 100303. ref SDS 23 FB67
041452 - ..
041453 - 6. Lymphedema has increased in the right arm, which requires
041454 - taking blood pressure and heart rate from my lower leg
041455 - (reported by Anne in the Chemotherapy Clinic on 100317 0730.
041456 - ref SDS 20 QR4X], and requires drawing blood from the Power
041457 - Port, rather than using the arms [... Millie requested support
041458 - from the doctor to assist the Chemotherapy Clinic balance
041459 - conflicting protocols in favor of patient safety to draw blood
041460 - for lab tests from the Power Port, reported on 100204 1325.
041461 - ref SDS 6 SB8U...]
041463 - ..
041464 - [On 100330 0830 Doctor Johnson again observed rising
041465 - lymphedema in Millie's right arm, signaling beginning of
041466 - IBC, and which Kaiser protocol prevents needle penetrations
041467 - for blood draws, taking blood pressure on the right arm, as
041468 - well as the left arm. ref SDS 23 C54N
041470 - ..
041471 - [On 100427 0830, during examination at Kaiser Doctor
041472 - Johnson entered in Millie's medical chart work plan
041473 - instruction to use Power Port for blood draws due to
041474 - bilateral lymphedema. ref SDS 24 X74Q
041476 - ..
041477 - 7. Since the cancer marker CA 15-3 369 dropped significantly from
041478 - 426 for the blood test 2 weeks ago, which was after the 2nd
041479 - treatment with Abraxane [reported in Millie's letter to the
041480 - medical team on 100319 0843, ref SDS 21 1T3Y], I am hopeful for
041481 - further decline after the 3rd treatment of the 1st cycle, and
041482 - which will be reported possibly tomorrow afternoon, or
041483 - Wednesday for the lab today.
041484 -
041485 - [On 100330 0830 Doctor Johnson finds during examination at
041486 - Kaiser that first cycle of treatment with Abraxane has
041487 - reduced Millie's cancer, ref SDS 23 FB9Y, including "drying
041488 - up" of IBC nodules. ref SDS 23 HR9K, and, so orders
041489 - starting 2nd cycle of Abraxane of 100303. ref SDS 23 FB67
041491 - ..
041492 - 8. Energy declined and pain increased during last week, which was
041493 - the "bye-week" when no chemotherapy was given. Spent a good
041494 - deal of time in bed [reflecting concerns in the letter to the
041495 - medical team on 100301 0005. ref SDS 9 OO4Y]. On several days
041496 - had to increase Percocet (oxycodone) to 2-pills every 3 hours
041497 - from original prescription for 1 every 4 hours, and based on
041498 - your approval several cycles ago. Thanks very much for
041499 - approving refill for Percocet last Friday. This ensured I
041500 - would have pain medication over the weekend.
041502 - ..
041503 - 9. Pain persists on my right forehead, head, and now has
041504 - progressed down my neck to across my upper back. Hopefully,
041505 - this is not shingles related. My forehead at least does not
041506 - show shingles blisters.
041507 -
041508 - [On 100330 0830 Doctor Johnson examination finds no
041509 - evidence of shingles recurrence, makes no assessment of the
041510 - cause for increased pain on the forehead, head, neck, and
041511 - across the upper back, ref SDS 23 FU5F, which was reported
041512 - to the medical team the day before on 100329, ref SDS 0
041513 - WA8Y; the doctor does not extend prescription for Acyclovir
041514 - (Zovirax) medication to be prepared for shingles
041515 - recurrence, requested on 100305, ref SDS 13 0W3T, and
041516 - rather than prescribe treatment targeted to Millie's
041517 - cancer, and which does not cause painful side effects, and
041518 - does not require Neupogen to recover blood counts, the
041519 - doctor prescribed additional pain medication with morphine,
041520 - which Millie can supplement with Percocet to treat
041521 - "breakthrough pain" from rising cancer, and side effects of
041522 - Abraxane chemotherapy and Neupogen. ref SDS 23 QX3K
041524 - ..
041525 - 10. The past 2 days I have been more energetic. On Saturday went
041526 - to Lafayette Reservoir for the 1st time in 6 or 8 months.
041527 - Walked up and down the dam, while Rod did a few laps.
041528 -
041529 - [On 100330 0830 Doctor Johnson indicated that continued
041530 - improved breathing aligns with CT test showing reduced
041531 - radiation injury from treatment at UCSF. ref SDS 23 FB85
041533 - ..
041534 - 11. Critical issue is identifying trade-offs comparing alternate
041535 - oncology treatments to recover from the next progression, as
041536 - requested in the letter to the medical team on 100319 0843,
041537 - ref SDS 21 1T5V
041538 -
041539 - [On 100330 0830 Doctor Johnson did not have time to provide
041540 - standard of care comparing trade-offs on treatments for
041541 - Millie to recover from UCSF medical mistakes. ref SDS 23
041542 - ZV4N
041544 - ..
041545 - [On 100501 1037 Millie's cancer marker rises to CA 15-3 424
041546 - for lab on 100424, ref SDS 25 U44U, highest in patient
041547 - history; examination on 100426 found cancer; worsening;
041548 - Millie reports cancer continues to rise after examination
041549 - on 100426, she fears losing control, ref SDS 25 U46W; she
041550 - requests changing treatments, ref SDS 25 U44V; and,
041551 - requests again standard of care trade-offs for treatments
041552 - comparing effectiveness, side effects, and cost.
041553 - ref SDS 25 U45R
041554 -
041561 -
041562 -
041563 -
041564 -
041565 -
041566 -
041567 -
041568 -
041569 -
0416 -